LCN2 and Nephropathy: Newer biomarkers of kidney damage could also be considered, e.g., Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Beta-Trace Protein (BTP), Beta-2 Microglobulin (B2M), Uromodulin, Asymmetric Dimethylarginine (ADMA), Symmetric Dimethylarginine (SDMA), Metabolomic and Proteomic Biomarkers, and MicroRNAs (miRNAs), depending on the capabilities of the center itself.